Loading clinical trials...
Loading clinical trials...
Open-label Study to Assess Aesthetic Improvement Following Treatment With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines
Conditions
Interventions
QM1114-DP
Locations
1
United States
Galderma Research Site
New York, New York, United States
Start Date
January 23, 2023
Primary Completion Date
March 31, 2023
Completion Date
June 23, 2023
Last Updated
March 27, 2024
NCT05481931
NCT06411002
NCT04985916
NCT05146999
NCT05277337
NCT03911102
Lead Sponsor
Galderma R&D
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions